Scilex Holding Company Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $31.6M-44.1% YoYTTM through 30 Jun 2026
Net Income -$464.6MTTM through 30 Jun 2026
Free Cash Flow -$17.8MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Operating Margin | -1,141.9% |
| Net Margin | -1,469.8% |
Returns
150.7%ROE
-102.5%ROA
Balance Sheet Health
Debt / Equity-0.26x
Current Ratio0.07x
Net Debt$80.2M
Cash & Equivalents$566K
Quality Metrics
Altman Z-Score-12.72
Piotroski F-Score3 / 9
FCF Margin-56.3%
Earnings-Beat Rate0.0%
Multi-Year Trend
RevenueFY2025: $30.3M
Diluted EPSFY2025: $-33,900.00
Dividend
No dividend
Capital Allocation
R&D Spend$18.6M
Capex Intensity2.3%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.